Analysis of the Efficacy and Stability of a Wearable ECG Monitor

N/ANot Yet RecruitingNCT06546046

Mezoo Co., Ltd.100 enrolled

Overview

This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring. After the data collection is completed, a satisfaction survey will be conducted with the medical staff. The data obtained simultaneously from HiCardi+ and MX40 will be analyzed, and the satisfaction survey responses from the medical staff will be reviewed to confirm the clinical convenience of the patch-type ECG monitoring device.

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Masking

NONE

Enrollment

100

Conditions

Arrhythmias, Cardiac Bradycardia Tachycardia Atrial Fibrillation Atrial Flutter Ventricular Premature Complexes

Interventions

ECG monitoring by telemetry device and patch-type ECG monitor at the same timeDEVICE

The patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adults aged 19 years or older 2. Patients admitted to Chonnam National University Hospital who require ECG monitoring 3. Individuals who have expressed their intention to participate in this study or have obtained written consent from a proxy Exclusion Criteria: 1. Individuals who are unable to provide consent themselves or through a legally designated representative 2. Individuals deemed unsuitable for participation in the clinical trial based on the researcher's judgment